Product Images Clopidogrel

Clopidogrel is a medication available in tablet form. Each tablet contains 97.875 mg of clopidogrel bisulfate which is equivalent to 75 mg of clopidogrel base. The usual dosage is mentioned on the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). A Medication Guide is available for patients and it can be accessed at www.macleodspharma.com/usa. The tablets are manufactured by Macleods Pharmaceuticals Ltd, Baddi, Himachal Pradesh, INDIA and distributed by Macleods Pharma USA, Inc. The NDC number for this medication is 33342-060-07.*

Each tablet contains 97.875 mg of clopidogrel bisufate, USP equivalent to 75 mg of clopidogrel base. Clopidogrel usual dosage is BEPARER. The tablets are 45x28 mm and should be stored between 20°C to 25°C (68° to 77°F), with excursions permitted to 15°C to 30°C (50 to 86° F) [see USP Reau s © | Controlled Room Temperature]. The package insert should be consulted for further details. This product is sold by Pharmascs and the website is wokmadeodsphama.comiusa. The place of origin is Naciecas ShamaUSA, Magaoss Prarmacescsi. The product name is not available due to incomplete text.*

This text is a description of a medication called clopidogrel, which comes in tablet form. Each tablet contains 97.875 mg of clopidogrel bisulfate, USP. This is equivalent to 75 mg of clopidogrel base. The usual dosage is specified in the package insert. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted. The pharmacist is instructed to give each patient an enclosed Medication Guide. The medication is manufactured by Macleods Pharma USA, Inc. The code number is HP/152/07. There are 90 tablets available.*

This is a description of a medication called Clopidogrel Tablets, USP 75 mg manufactured by Macleods Pharma USA. The medication guide is available on their website. Each bottle contains 100 tablets with a batch number of 12|9. The tablets should be stored at room temperature with excursions permitted. It is recommended to see the package insert for dosage instructions.*

The text provides a comparison between two medications, PLACEBO (+ aspirin)® and CLOPIDOGREL (+ aspirin), over a follow-up period of 12 months. A result of 0.00009 is shown in the comparison. Other standard therapies were also used during the study.*

This is a clinical trial report that compares the effect of clopidogrel against placebo on the survival rate of patients. Both groups of participants received aspirin. The study found that the group treated with clopidogrel had a 7% proportional risk reduction of death compared to the placebo group. The report includes a graph showing the mortality rate over time for the two groups.*

This is a medical report providing the names of two medications, Aspirin and Clopidogrel. Additionally, there is a statistical value of P=0.045, and mention of months of follow-up. No further information is available for a complete description of the medical study or report.*

This text seems to be a mix of random numbers and letters without proper context. It is not-available for creating a useful description.*